National Allergy Strategy Funding - 5 April 2019

Critical attention needs to be given to the healthcare of Australians with allergic disease.

Allergy & Anaphylaxis Australia,  together with ASCIA (Australasian Society of Clinical Immunology and Allergy) are calling on the federal government to commit $20m to fund the National Allergy Strategy to deliver better care for Australians living with allergic disease.

Read more about our current situation and the proposed solutions:

Go to National Allergy Strategy webpage: Crisis in the Care of Allergic Patients in Australia

Download National Allergy Strategy media release: Crisis in the Care of Allergic Patients in Australia PDF

 

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.